INTERNATIONAL INSTITUTE OF PSYCHO PHARMACOLOGY

Our Vision

The IIPP was established in 2003 as an interdisciplinary research institute that brings together expertise from the fields of medicine, pharmacology and mental health to make advances in the clinical care of mental health patients. Our focus is on identifying protocols for diagnosis, medication and treatment that will make a real difference in mental health care.

Under the Institute's auspices we also run a registered psychiatric hospital as the Melbourne MediBrain Centre. Follow this link to the Melbourne MediBrain Centre to find out more about the services offered.

As a research institute our aim to be an Australia thought leader in psycho pharmacological research through the application of innovative research programs that will lead to better understandings about mental health disorders and deliver improved clinical care and treatments in mental health. 

We do this by:

  • Conducting interdisciplinary research drawing on expertise and methodology across medical disciplines to improve clinical outcomes in mental health.
  • Developing standardised comprehensive assessment tools to provide diagnosis, treatment and positive outcomes for mental health disorders.
  • Formulating research that will cultivate objective measures of brain function as the basis for evidence based clinical care for mental health patients.
  • Sharing our findings and knowledge with organisations, practitioners and carers who have a mutual interest in improving treatment in mental health.

Our Research

The institute has had many projects in a range of research and related projects both here and overseas since its inception in 2003. We provide here a small selection of projects as an example of our research focus.

Current Projects

Pilot Study to Evaluate a Centralised Model for Provision of Psychiatric Services for Veterans Suffering from Post Traumatic Stress Disorder (PTSD).

PTSD is a complex disorder and is often presented as a range symptoms that can vary across a broad range of factors that manifest themselves in varying degrees of severity further complicated by contributing factors with moderate or severe impacts on sufferers lives.



This pilot study will evaluate the efficacy of a Referral Triage Service conducted by specifically trained psychiatric staff with expertise in the identification, classification and treatment of current and returned defence personnel suffering from PTSD.

If you'd like to find out more about this project please contact us.


Past Research Projects

  • Study Into The Effects Of Agomelatine (25 To 50 Mg/Day) On Sleep EEG Parameters Compared To Duloxetine In Patients With Major Depressive Disorder.
  • ​Multicentre Randomised, Blinded, Controlled Parallel Group Trial To Demonstrate The Efficacy Of Reeg Guided Pharmacotherapy Of Subjects With Treatment-Resistant Depression.
  • ​Investigation Into The Attitudes Of Mental Health Participants Regarding Treatment and Research Participation.
  • ​Long Term Open Comparison Of Ziprasidone Versus Active Comparator In Chronic Schizophrenia And Schizoaffective Disorder: A 26 Week Study.
  • ​Study Into The Effects Of Aging And Dementia On Prospective Memory With Relevance To Compliance With Medication Regimens.
  • ​Multicentre, Double Blinded, Randomised Comparative Study Of Aripiprazole and Olazapine In The Treatment Of Patients With Acute Schizophrenia.
  • ​Study Into The Risk Factors For Compliance With Command Hallucinations In Psychotic Disorders.
  • Australian Participant And Contributor To The International Study of the Molecular Genetics Of Schizophrenia, Utilising The DIGS Model (Diagnostic Interview For Genetic Studies).
  • An 8-16 Week Multicentre, Open, Non-Compartive Dose Titration Study Of The Safety, Efficacy And Tolerance Of Sertaline (50 To 200 Mg) In The Treatment Of Major Depression In Patients Who Have Not Responded to an Adequate Trial Of Moclobemide Therapy.
  • Study To Address Improvements In Clinical Care For Patients Receiving Clozapine In An Effort To Manage And Minimise Significant Side Effects Including Neutropenia, Metabolic Syndrome, Cardiac Problems And Glucose Intolerance.
  • Study Into The Effect Of Bipolar Disorder On Memory Investigating Specifically Bipolar Disorder as it Effects Prospective Memory.

Latest News

The International Institute of Psycho Pharmacology and The Melbourne Medibrain Centre announce a new research project to assist sufferers of PTSD.



PTSD is a complex disorder and is often presented as a range symptoms that can vary across a broad range of factors that manifest themselves in varying degrees of severity further complicated by contributing factors with moderate or severe impacts on sufferers lives.



IIPP and MediBrain are undertaking a pilot study which will evaluate the efficacy of a Referral Triage Service conducted by specifically trained psychiatric staff with expertise in the identification, classification and treatment of current and returned defence personnel suffering from PTSD.



Aimed specifically at current and returned military personnel, we are seeking to develop an evidence based best practice for early intervention in support for PTSD sufferers. Medibrain will be conducting the clinical treatment research component and will be seeking participants for the treatment program.

You can find out more about this program here.


Join Our Team of Talented Researchers

IIPP is always seeking to form meaningful relationships with like-minded, result focused organisations and individuals.

If you would like to be affiliated to our research programs or have a project in mind that is aligned to our objectives, we would love to hear from you.

css.php